How alcohol opens the floodgates for harmful bacteria to reach the liver

Alcohol-associated liver disease (ALD) is a major cause of liver transplantation and death worldwide, and its impact is only growing. In 2022, the annual cost of ALD in the United States was $31 billion. By 2040, this number could be as high as $66 billion. ALD has limited therapeutic options, so scientists are looking for new ways to target the molecular biology of ALD to help prevent its occurrence or reduce its severity.

This article was originally published on MedicalXpress.com

You may also be interested in:

Read More:

Lawyers Lookup